Angelini Ventures logo

Angelini Ventures

Europe, Lazio, Italy, Rome

Description

Angelini Ventures is an investment firm.

Investor Profile

Angelini Ventures has made 14 investments, with 5 in the past 12 months and 36% as lead.

Stage Focus

  • Series A (36%)
  • Series C (21%)
  • Series B (14%)
  • Seed (14%)
  • Pre Seed (7%)
  • Series Unknown (7%)

Country Focus

  • United States (50%)
  • Italy (21%)
  • Switzerland (7%)
  • Belgium (7%)
  • Denmark (7%)
  • Germany (7%)

Industry Focus

  • Health Care
  • Therapeutics
  • Biotechnology
  • Pharmaceutical
  • Medical
  • Medical Device
  • Neuroscience
  • Mobile Devices
  • Wearables
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Angelini Ventures frequently co-invest with?

Bristol-Myers Squibb
North America, New York, United States, New York
Co-Investments: 1
Asahi Kasei
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
JDRF T1D Fund
North America, Massachusetts, United States, Boston
Co-Investments: 1
Lumira Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 1
TI
Europe, Bayern, Germany, Munich
Co-Investments: 2
AW
North America, Florida, United States, Miami
Co-Investments: 1
Bayern Kapital
Europe, Bayern, Germany, Landshut
Co-Investments: 2
Roche Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
AL
North America, Maryland, United States, Rockville
Co-Investments: 1

Which angels does Angelini Ventures often collaborate with?

AC
Europe, Lombardia, Italy, Milan
Shared Deals: 1

What are some of recent deals done by Angelini Ventures?

Vantis Vascular

San Jose, California, United States

Vantis Vascular develops technology for vascular interventions targeting complex arteries.

AppsHealth CareInformation TechnologyMedicalMedical Device
Series UnknownMar 12, 2025
Amount Raised: $10,885,681
Vantis

Munich, Bayern, Germany

Vantis is a digital solution for chronic cardiovascular diseases that requires personalized ongoing treatment for decades.

Health Care
Series AMar 12, 2025
Amount Raised: $10,911,539
Nobi

Antwerpen, Antwerpen, Belgium

Nobi is an AI-powered smart lamp.

Artificial Intelligence (AI)
Series BJan 28, 2025
Amount Raised: $36,510,589
Neumirna Therapeutics

Copenhagen, Hovedstaden, Denmark

Neumirna Therapeutics is a Danish pharmaceutical start-up based in Copenhagen.

Pharmaceutical
Series AJan 8, 2025
Amount Raised: $20,708,264
Aptadir Therapeutics

Milan, Lombardia, Italy

Aptadir Therapeutics is developing a treatment for Myelodysplastic Neoplasms based on the capability of specific RNA therapeutics.

BiotechnologyHealth CareMedical
Pre SeedSep 24, 2024
Amount Raised: $1,600,000
Nouscom

Basel, Basel-Stadt, Switzerland

Nouscom is a biotech company working to develop a series of immunotherapeutics capable of selectively killing tumor cells.

BiotechnologyGeneticsHealth CareTherapeutics
Series CMar 21, 2024
Amount Raised: $7,603,472
Avation Medical

Columbus, Ohio, United States

Avation Medical is pioneering new platforms for wearable nerve stimulation systems.

Health CareMedicalMedical DeviceMobile DevicesNeuroscienceWearables
Series CFeb 1, 2024
Amount Raised: $22,000,000
Cour Pharmaceuticals Development

Skokie, Illinois, United States

Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

BiotechnologyPharmaceuticalTherapeutics
Series AJan 30, 2024
Amount Raised: $105,000,000
Noctrix Health

San Francisco, California, United States

Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.

Health CareMedical DeviceTherapeutics
Series CJan 16, 2024
Amount Raised: $40,000,000
Freya Biosciences

Boston, Massachusetts, United States

Freya Biosciences is a clinical-stage women’s health company pioneering a new class of microbial immunotherapies.

Life ScienceWomen's
Series ADec 12, 2023
Amount Raised: $38,000,000